Gu XT - Search Results

1

Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAc N-deacetylase/N-sulfotransferase-1 in human breast cancer.

He DX, Gu XT, Li YR, Jiang L, Jin J, Ma X. He DX, et al. Among authors: gu xt. FEBS J. 2014 Oct;281(20):4718-30. doi: 10.1111/febs.13012. Epub 2014 Sep 30. FEBS J. 2014. PMID: 25156775 Free article.

2

A methylation-based regulatory network for microRNA 320a in chemoresistant breast cancer.

He DX, Gu XT, Jiang L, Jin J, Ma X. He DX, et al. Among authors: gu xt. Mol Pharmacol. 2014 Nov;86(5):536-47. doi: 10.1124/mol.114.092759. Epub 2014 Aug 26. Mol Pharmacol. 2014. PMID: 25159093

3

A 20-gene signature in predicting the chemoresistance of breast cancer to taxane-based chemotherapy.

He DX, Xia YD, Gu XT, Jin J, Ma X. He DX, et al. Among authors: gu xt. Mol Biosyst. 2014 Dec;10(12):3111-9. doi: 10.1039/c4mb00464g. Epub 2014 Sep 11. Mol Biosyst. 2014. PMID: 25209432

4

A transcription/translation-based gene signature predicts resistance to chemotherapy in breast cancer.

He DX, Xia YD, Gu XT, Jin J, Ma X. He DX, et al. Among authors: gu xt. J Pharm Biomed Anal. 2015 Jan;102:500-8. doi: 10.1016/j.jpba.2014.10.018. Epub 2014 Oct 27. J Pharm Biomed Anal. 2015. PMID: 25459950

5

Genome-wide profiles of methylation, microRNAs, and gene expression in chemoresistant breast cancer.

He DX, Gu F, Gao F, Hao JJ, Gong D, Gu XT, Mao AQ, Jin J, Fu L, Ma X. He DX, et al. Among authors: gu xt. Sci Rep. 2016 Apr 20;6:24706. doi: 10.1038/srep24706. Sci Rep. 2016. PMID: 27094684 Free PMC article.

6

Genome-wide analysis of the three-way interplay among gene expression, estrogen receptor expression and chemotherapeutic sensitivity in breast cancer.

He DX, Wu XL, Lu CX, Gu XT, Zhang GY, Ma X, Liu DQ. He DX, et al. Among authors: gu xt. Oncol Rep. 2017 Dec;38(6):3392-3402. doi: 10.3892/or.2017.6033. Epub 2017 Oct 12. Oncol Rep. 2017. PMID: 29039577 Free PMC article.

7

Methylation of Notch3 modulates chemoresistance via P-glycoprotein.

Gu X, Lu Y, He D, Lu C, Jin J, Lu X, Ma X. Gu X, et al. Eur J Pharmacol. 2016 Dec 5;792:7-14. doi: 10.1016/j.ejphar.2016.10.024. Epub 2016 Oct 22. Eur J Pharmacol. 2016. PMID: 27780727

8

A new agent developed by biotransformation of polyphyllin VII inhibits chemoresistance in breast cancer.

He DX, Li GH, Gu XT, Zhang L, Mao AQ, Wei J, Liu DQ, Shi GY, Ma X. He DX, et al. Among authors: gu xt. Oncotarget. 2016 May 31;7(22):31814-24. doi: 10.18632/oncotarget.6674. Oncotarget. 2016. PMID: 26701723 Free PMC article.

9

Genome-wide profiling of long non-coding RNA expression patterns in anthracycline-resistant breast cancer cells.

He DX, Zhang GY, Gu XT, Mao AQ, Lu CX, Jin J, Liu DQ, Ma X. He DX, et al. Among authors: gu xt. Int J Oncol. 2016 Oct;49(4):1695-1703. doi: 10.3892/ijo.2016.3665. Epub 2016 Aug 22. Int J Oncol. 2016. PMID: 27633960

10

Targeting PSG1 to enhance chemotherapeutic efficacy: new application for anti-coagulant the dicumarol.

He DX, Gu F, Wu J, Gu XT, Lu CX, Mao AQ, Zhang GY, Ding ZY, Wang JK, Hao JJ, Fu L, Ma X. He DX, et al. Among authors: gu xt. Clin Sci (Lond). 2016 Dec 1;130(24):2267-2276. doi: 10.1042/CS20160536. Epub 2016 Sep 21. Clin Sci (Lond). 2016. PMID: 27653744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters